Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stereotaxis (STXS)
NYSE MKT:STXS
Stereotaxis (STXS) Stock Price & Analysis
224 Followers
STXS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.33 - $3.29
Previous Close$1.9
Volume304.74K
Average Volume (3M)384.35K
Market Cap
$157.02M
Enterprise Value$144.78M
Total Cash (Recent Filing)$17.63M
Total Debt (Recent Filing)$5.39M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Aug 08, 2024EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding82,643,243
10 Day Avg. Volume224,975
30 Day Avg. Volume384,352
Standard Deviation0.19
R-Squared0.18
Alpha-0.00690
Financial Highlights & Ratios
Price to Book (P/B)6.86
Price to Sales (P/S)32.95
Price to Cash Flow (P/CF)-15.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.34
Enterprise Value/Gross Profit9.74
Enterprise Value/Ebitda-7.08
Forecast
1Y Price Target
$4.50Price Target Upside123.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Stereotaxis News
Bulls Say, Bears Say
Bulls Say
AcquisitionThe APT acquisition will give STXS new development and manufacturing capabilities and makes strategic sense.
Financial PerformanceSTXS continues to project overall double-digit revenue growth in 2024, ahead of expected breakout top-line growth starting next year.
Product Approvals2024 is set to be a transformative year with numerous product approvals across several geographies, resulting in a catalyst heavy year and a reinvigorated growth profile.
Bears Say
Earnings ImpactSystem revenue was impacted by delays in hospital construction schedules, affecting recent earnings.
Operational ChallengesThe ability to scale and expand margins has suffered from structural challenges and significant construction investment required by customers.
Revenue DeclineRevenue in 4Q’23 totaled $4.6M compared to $7.3M in 4Q'22 with system revenue hurt by delays in hospital construction schedules.
---
Ownership Overview
46.14% Insiders
5.30% Mutual Funds
5.28% Other Institutional Investors
43.28% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STXS FAQ
What was Stereotaxis’s price range in the past 12 months?
Stereotaxis lowest stock price was $1.33 and its highest was $3.29 in the past 12 months.
What is Stereotaxis’s market cap?
Currently, no data Available
When is Stereotaxis’s upcoming earnings report date?
Stereotaxis’s upcoming earnings report date is Aug 08, 2024 which is in 14 days.
How were Stereotaxis’s earnings last quarter?
Stereotaxis released its earnings results on May 13, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.062 by $0.002.
Is Stereotaxis overvalued?
According to Wall Street analysts Stereotaxis’s price is currently Undervalued.
Does Stereotaxis pay dividends?
Stereotaxis does not currently pay dividends.
What is Stereotaxis’s EPS estimate?
Stereotaxis’s EPS estimate is -$0.05.
How many shares outstanding does Stereotaxis have?
Stereotaxis has 82,643,240 shares outstanding.
What happened to Stereotaxis’s price movement after its last earnings report?
Stereotaxis reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.062. Following the earnings report the stock price went down -3.241%.
Which hedge fund is a major shareholder of Stereotaxis?
Among the largest hedge funds holding Stereotaxis’s share is GMT Capital Corp. It holds Stereotaxis’s shares valued at N/A.
---
Stereotaxis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.50 (123.88% Upside)
$4.50 (123.88% Upside)
Blogger Sentiment
Bullish
STXS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 126.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $32.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
27.51%
12-Months-Change
Fundamentals
Return on Equity
-80.58%
Trailing 12-Months
Asset Growth
-22.20%
Trailing 12-Months
Company Description
Stereotaxis
Stereotaxis, Inc. engages in the design, manufacture, and market of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. Its products include The Epoch Solution, Niobe Magnetic Navigation System, Vdrive Robotic Navigation System, and Odyssey Solution. The company was founded in June 1990 and is headquartered in St. Louis, MO.
---
STXS Company Deck
---
STXS Earnings Call
Q1 2024
0:00 / 0:00
---
STXS Stock 12 Month Forecast
Average Price Target
$4.50
▲(123.88% Upside)
Technical Analysis
Best Analysts Covering STXS
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
-0.45%
assigned a buy rating 5 months ago
Copying Alexander Nowak's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -0.45% per trade.
---